Free tool
Largest one day gains
The 50 largest one day percentage moves higher recorded at the latest close. The largest moves were BHVN at +17.9% and ERAS at +7.8%. By size, the list splits into 50 mid cap listings.
Switch view
All stocks50 of 23,178 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1D return | 1Y return |
|---|---|---|---|---|---|
| BHVN | Biohaven Ltd. | $2.56B | Mid cap | +17.87% | +8.65% |
| ERAS | Erasca, Inc. | $6.70B | Mid cap | +7.83% | +1112.03% |
| NBTX | Nanobiotix S.A. | $2.26B | Mid cap | +7.20% | +394.99% |
| ZYME | Zymeworks Inc. | $2.10B | Mid cap | +6.68% | +96.28% |
| XENE | Xenon Pharmaceuticals Inc. | $6.18B | Mid cap | +5.58% | +64.11% |
| VERA | Vera Therapeutics, Inc. | $2.65B | Mid cap | +4.37% | +67.21% |
| PVLA | Palvella Therapeutics, Inc. | $2.22B | Mid cap | +4.11% | +173.39% |
| KLRA | Kailera Therapeutics, Inc. | $2.39B | Mid cap | +3.89% | −29.08% |
| NEO | NeoGenomics, Inc. | $2.26B | Mid cap | +3.45% | +145.34% |
| AXGN | AxoGen, Inc. Common Stock | $2.68B | Mid cap | +3.30% | +219.58% |
| WGS | GeneDx Holdings Corp. | $2.69B | Mid cap | +3.30% | −30.11% |
| ALMR | Alamar Biosciences, Inc. | $2.36B | Mid cap | +3.21% | +54.91% |
| SRRK | Scholar Rock Holding Corporation | $7.31B | Mid cap | +3.07% | +74.18% |
| CELC | Celcuity Inc. | $4.65B | Mid cap | +3.05% | +90.31% |
| MMED | MiniMed Group, Inc. | $5.48B | Mid cap | +3.01% | +5.41% |
| CLOV | Clover Health Investments, Corp. | $2.26B | Mid cap | +2.91% | +57.99% |
| SRPT | Sarepta Therapeutics, Inc. | $2.06B | Mid cap | +2.85% | +7.69% |
| TNGX | Tango Therapeutics, Inc. | $4.29B | Mid cap | +2.83% | +269.13% |
| RAPP | Rapport Therapeutics, Inc. | $2.52B | Mid cap | +2.60% | +250.70% |
| ACHC | Acadia Healthcare Company, Inc. | $2.85B | Mid cap | +2.38% | +37.81% |
| ALHC | Alignment Healthcare, Inc. | $2.88B | Mid cap | +2.28% | −13.88% |
| LGND | Ligand Pharmaceuticals Incorporated | $5.74B | Mid cap | +2.18% | +80.92% |
| PRGO | Perrigo Company plc | $2.05B | Mid cap | +1.93% | −36.05% |
| PGEN | Precigen, Inc. | $2.65B | Mid cap | +1.92% | +61.66% |
| HRMY | Harmony Biosciences Holdings, Inc. | $2.31B | Mid cap | +1.82% | +4.23% |
| OPCH | Option Care Health, Inc. | $3.60B | Mid cap | +1.69% | −15.91% |
| NVCR | NovoCure Limited | $2.08B | Mid cap | +1.53% | +50.21% |
| PBH | Prestige Consumer Healthcare Inc. | $2.47B | Mid cap | +1.36% | −22.12% |
| LQDA | Liquidia Corporation | $6.31B | Mid cap | +1.23% | +154.86% |
| NVST | Envista Holdings Corporation | $4.47B | Mid cap | +1.20% | +30.89% |
| ARQT | Arcutis Biotherapeutics, Inc. | $3.12B | Mid cap | +1.13% | +60.64% |
| PACS | PACS Group, Inc. | $7.03B | Mid cap | +1.02% | +274.28% |
| OSCR | Oscar Health, Inc. | $9.55B | Mid cap | +1.00% | +83.55% |
| IMVT | Immunovant, Inc. | $9.07B | Mid cap | +0.90% | +189.13% |
| CHE | Chemed Corporation | $7.11B | Mid cap | +0.84% | +20.79% |
| HCM | HUTCHMED (China) Limited | $2.15B | Mid cap | +0.73% | −17.45% |
| LIVN | LivaNova PLC | $4.41B | Mid cap | +0.71% | +41.56% |
| HNGE | Hinge Health, Inc. | $7.25B | Mid cap | +0.70% | +56.66% |
| VKTX | Viking Therapeutics, Inc. | $4.01B | Mid cap | +0.61% | +29.15% |
| PTGX | Protagonist Therapeutics, Inc. | $9.80B | Mid cap | +0.60% | +146.62% |
| VCYT | Veracyte, Inc. Common Stock | $3.56B | Mid cap | +0.57% | +54.81% |
| AVTR | Avantor, Inc. | $9.81B | Mid cap | +0.55% | +9.93% |
| NEOG | Neogen Corporation | $2.54B | Mid cap | +0.52% | +103.83% |
| CON | Concentra Group Holdings Parent, Inc. | $4.44B | Mid cap | +0.49% | +50.93% |
| GRDN | Guardian Pharmacy Services, Inc. | $2.36B | Mid cap | +0.48% | +45.50% |
| MANE | Veradermics, Incorporated | $4.29B | Mid cap | +0.44% | +172.32% |
| MIRM | Mirum Pharmaceuticals, Inc. | $5.98B | Mid cap | +0.44% | +31.96% |
| ESTA | Establishment Labs Holdings Inc. | $2.15B | Mid cap | +0.42% | +70.71% |
| AMRX | Amneal Pharmaceuticals, Inc. | $6.27B | Mid cap | +0.39% | +92.20% |
| ATR | AptarGroup, Inc. | $8.60B | Mid cap | +0.39% | −1.89% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.
Micro and small cap listings are left out, so the list describes the market rather than thin trading, as are moves beyond 1,000% in a session, which are corporate actions the price series has not been restated for. This is a description of one day of price movement, nothing more. It says nothing about any company behind it.